Literature DB >> 20007723

Utility of the k-means clustering algorithm in differentiating apparent diffusion coefficient values of benign and malignant neck pathologies.

A Srinivasan1, C J Galbán, T D Johnson, T L Chenevert, B D Ross, S K Mukherji.   

Abstract

BACKGROUND AND
PURPOSE: Does the K-means algorithm do a better job of differentiating benign and malignant neck pathologies compared to only mean ADC? The objective of our study was to analyze the differences between ADC partitions to evaluate whether the K-means technique can be of additional benefit to whole-lesion mean ADC alone in distinguishing benign and malignant neck pathologies.
MATERIAL AND METHODS: MR imaging studies of 10 benign and 10 malignant proved neck pathologies were postprocessed on a PC by using in-house software developed in Matlab. Two neuroradiologists manually contoured the lesions, with the ADC values within each lesion clustered into 2 (low, ADC-ADC(L); high, ADC-ADC(H)) and 3 partitions (ADC(L); intermediate, ADC-ADC(I); ADC(H)) by using the K-means clustering algorithm. An unpaired 2-tailed Student t test was performed for all metrics to determine statistical differences in the means of the benign and malignant pathologies.
RESULTS: A statistically significant difference between the mean ADC(L) clusters in benign and malignant pathologies was seen in the 3-cluster models of both readers (P = .03 and .022, respectively) and the 2-cluster model of reader 2 (P = .04), with the other metrics (ADC(H), ADC(I); whole-lesion mean ADC) not revealing any significant differences. ROC curves demonstrated the quantitative differences in mean ADC(H) and ADC(L) in both the 2- and 3-cluster models to be predictive of malignancy (2 clusters: P = .008, area under curve = 0.850; 3 clusters: P = .01, area under curve = 0.825).
CONCLUSIONS: The K-means clustering algorithm that generates partitions of large datasets may provide a better characterization of neck pathologies and may be of additional benefit in distinguishing benign and malignant neck pathologies compared with whole-lesion mean ADC alone.

Entities:  

Mesh:

Year:  2009        PMID: 20007723      PMCID: PMC4283555          DOI: 10.3174/ajnr.A1901

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  8 in total

1.  Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings.

Authors:  Vincent Vandecaveye; Frederik De Keyzer; Sandra Nuyts; Karen Deraedt; Piet Dirix; Pascal Hamaekers; Vincent Vander Poorten; Pierre Delaere; Robert Hermans
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-04       Impact factor: 7.038

2.  Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes.

Authors:  Konstantin Holzapfel; Sabrina Duetsch; Claudius Fauser; Matthias Eiber; Ernst J Rummeny; Jochen Gaa
Journal:  Eur J Radiol       Date:  2008-11-07       Impact factor: 3.528

3.  Evaluation of the larynx for tumour recurrence by diffusion-weighted MRI after radiotherapy: initial experience in four cases.

Authors:  V Vandecaveye; F de Keyzer; V Vander Poorten; K Deraedt; H Alaerts; W Landuyt; S Nuyts; R Hermans
Journal:  Br J Radiol       Date:  2006-04-26       Impact factor: 3.039

4.  Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging.

Authors:  J Wang; S Takashima; F Takayama; S Kawakami; A Saito; T Matsushita; M Momose; T Ishiyama
Journal:  Radiology       Date:  2001-09       Impact factor: 11.105

5.  Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck.

Authors:  Masayuki Maeda; Hiroya Kato; Hajime Sakuma; Stephan E Maier; Kan Takeda
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

6.  Differentiation of benign and malignant pathology in the head and neck using 3T apparent diffusion coefficient values: early experience.

Authors:  A Srinivasan; R Dvorak; K Perni; S Rohrer; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-05       Impact factor: 3.825

Review 7.  Usefulness of diffusion-weighted imaging and the apparent diffusion coefficient in the assessment of head and neck tumors.

Authors:  Masayuki Maeda; Stephan E Maier
Journal:  J Neuroradiol       Date:  2008-03-05       Impact factor: 3.447

Review 8.  Diffusion-weighted magnetic resonance imaging in neck lymph adenopathy.

Authors:  Vincent Vandecaveye; Frederik De Keyzer; Robert Hermans
Journal:  Cancer Imaging       Date:  2008-09-30       Impact factor: 3.909

  8 in total
  9 in total

1.  Differentiation between benign and malignant orbital tumors at 3-T diffusion MR-imaging.

Authors:  Ahmed Abdel Khalek Abdel Razek; Sahar Elkhamary; Amani Mousa
Journal:  Neuroradiology       Date:  2011-02-01       Impact factor: 2.804

2.  Multiparametric magnetic resonance imaging of brain disorders.

Authors:  Ona Wu; Rick M Dijkhuizen; Alma Gregory Sorensen
Journal:  Top Magn Reson Imaging       Date:  2010-04

3.  Fuzzy C-means clustering of magnetic resonance imaging on apparent diffusion coefficient maps for predicting nodal metastasis in head and neck cancer.

Authors:  Ming-Che Lee; Keh-Shih Chuang; Mu-Kuan Chen; Chi-Kuang Liu; Kwo-Whei Lee; Hui-Yu Tsai; Hsin-Hon Lin
Journal:  Br J Radiol       Date:  2016-05-11       Impact factor: 3.039

4.  Non-invasive quantification of tumour heterogeneity in water diffusivity to differentiate malignant from benign tissues of urinary bladder: a phase I study.

Authors:  Huyen T Nguyen; Zarine K Shah; Amir Mortazavi; Kamal S Pohar; Lai Wei; Guang Jia; Debra L Zynger; Michael V Knopp
Journal:  Eur Radiol       Date:  2016-08-23       Impact factor: 5.315

5.  Prediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters.

Authors:  Huyen T Nguyen; Guang Jia; Zarine K Shah; Kamal Pohar; Amir Mortazavi; Debra L Zynger; Lai Wei; Xiangyu Yang; Daniel Clark; Michael V Knopp
Journal:  J Magn Reson Imaging       Date:  2014-06-19       Impact factor: 4.813

6.  Concordance of FDG PET/CT metabolic tumour volume versus DW-MRI functional tumour volume with T2-weighted anatomical tumour volume in cervical cancer.

Authors:  Alta Y T Lai; Jose A U Perucho; Xiaopei Xu; Edward S Hui; Elaine Y P Lee
Journal:  BMC Cancer       Date:  2017-12-06       Impact factor: 4.430

7.  Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer.

Authors:  Marco Rengo; Simona Picchia; Simona Marzi; Davide Bellini; Damiano Caruso; Mauro Caterino; Maria Ciolina; Domenico De Santis; Daniela Musio; Vincenzo Tombolini; Andrea Laghi
Journal:  Oncotarget       Date:  2017-10-10

Review 8.  High-Throughput Metabolomics by 1D NMR.

Authors:  Alessia Vignoli; Veronica Ghini; Gaia Meoni; Cristina Licari; Panteleimon G Takis; Leonardo Tenori; Paola Turano; Claudio Luchinat
Journal:  Angew Chem Int Ed Engl       Date:  2018-11-11       Impact factor: 15.336

9.  Quantitative Assessment of Heterogeneity in Bladder Tumor MRI Diffusivity: Can Response be Predicted Prior to Neoadjuvant Chemotherapy?

Authors:  Huyen T Nguyen; Amir Mortazavi; Kamal S Pohar; Debra L Zynger; Lai Wei; Zarine K Shah; Guang Jia; Michael V Knopp
Journal:  Bladder Cancer       Date:  2017-10-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.